Muscle Gaining Anabolic Steroid Masteron Enanthate Drostanolone Enanthate 472-61-145

Muscle Gaining Anabolic Steroid Masteron Enanthate                           Drostanolone Enanthate

Description:

Drostanolone enanthate is an ester of drostanolone. Drostanolone is indicated in postmenopausal women

with recurrent breast cancer, in combined hormone therapy. Drostanolone causes retention of nitrogen,

potassium, and phosphorus; Increases protein anabolism; And decreases amino acid catabolism.

The antitumor activity of drostanolone appears related to reduction or competitive inhibition of prolactin

receptors or estrogen receptors or production.

Drostanolone enanthate 200 USP injection provides drostanolone enanthate, a potent androgenic steroid

that has similar characteristics of dihydrotestosterone. Drostanolone is incapable of aromization and

therefore it doesn't convert into oestrogen. Both drostanolone's anabolic and androgenic activity are far

greater than methyl testosterone. The esterification of the 17-beta-hydroxyl group increases the duration

of the action of drostanolone. Drostanolone esters in oil injected intramuscularly are absorbed slowly from

the lipid phase, thus Drostanolone enanthate 200 can be administered at intervals of every 1-2 weeks.

Drostanolone enanthate 200 contains drostanolone enanthate in a 10ml solution for injection (200mg

drostanolone enanthate /ml).
 

Applications:

Drostanolone enanthate is an ester of drostanolone. Drostanolone is indicated in postmenopausal women

with recurrent breast cancer, in combined hormone therapy. Drostanolone causes retention of nitrogen,

potassium, and phosphorus; increases protein anabolism; and decreases amino acid catabolism.

The antitumor activity of drostanolone appears related to reduction or competitive inhibition of prolactin

receptors or estrogen receptors or production.

Drostanolone enanthate 200 USP injection provides drostanolone enanthate, a potent androgenic steroid

that has similar characteristics of dihydrotestosterone. Drostanolone is incapable of aromization and

therefore it doesn’t convert into oestrogen. Both drostanolone’s anabolic and androgenic activity are far

greater than methyl testosterone. The esterification of the 17-beta-hydroxyl group increases the duration

of the action of drostanolone. Drostanolone esters in oil injected intramuscularly are absorbed slowly from

the lipid phase, thus Drostanolone enanthate 200 can be administered at intervals of every 1-2 weeks.

COA